 | • レポートコード：MRC2-11QY11432 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結腸・直腸がんのグローバル市場について調査・分析したレポートです。種類別（大腸がん治療、直腸がん治療）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結腸・直腸がんの競争状況、市場シェア ・世界の結腸・直腸がん市場：種類別市場規模 2015年-2020年（大腸がん治療、直腸がん治療） ・世界の結腸・直腸がん市場：種類別市場規模予測 2021年-2026年（大腸がん治療、直腸がん治療） ・世界の結腸・直腸がん市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の結腸・直腸がん市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の結腸・直腸がん市場分析：米国、カナダ ・ヨーロッパの結腸・直腸がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結腸・直腸がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結腸・直腸がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結腸・直腸がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Bayer Healthcare、Spectrum、Novartis、Amgen、Roche、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Colon & Rectal Carcinoma Market
The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Colon & Rectal Carcinoma Scope and Market Size
Colon & Rectal Carcinoma market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colon & Rectal Carcinoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
…
Market segment by Type, the product can be split into
Colon Carcinoma Treatment
Rectal Carcinoma Treatment
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Colon & Rectal Carcinoma Revenue
1.4 Market by Type
1.4.1 Global Colon & Rectal Carcinoma Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Colon Carcinoma Treatment
1.4.3 Rectal Carcinoma Treatment
1.5 Market by Application
1.5.1 Global Colon & Rectal Carcinoma Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Colon & Rectal Carcinoma Market Perspective (2015-2026)
2.2 Global Colon & Rectal Carcinoma Growth Trends by Regions
2.2.1 Colon & Rectal Carcinoma Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colon & Rectal Carcinoma Historic Market Share by Regions (2015-2020)
2.2.3 Colon & Rectal Carcinoma Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Colon & Rectal Carcinoma Market Growth Strategy
2.3.6 Primary Interviews with Key Colon & Rectal Carcinoma Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Colon & Rectal Carcinoma Players by Market Size
3.1.1 Global Top Colon & Rectal Carcinoma Players by Revenue (2015-2020)
3.1.2 Global Colon & Rectal Carcinoma Revenue Market Share by Players (2015-2020)
3.1.3 Global Colon & Rectal Carcinoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Colon & Rectal Carcinoma Market Concentration Ratio
3.2.1 Global Colon & Rectal Carcinoma Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Colon & Rectal Carcinoma Revenue in 2019
3.3 Colon & Rectal Carcinoma Key Players Head office and Area Served
3.4 Key Players Colon & Rectal Carcinoma Product Solution and Service
3.5 Date of Enter into Colon & Rectal Carcinoma Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Colon & Rectal Carcinoma Historic Market Size by Type (2015-2020)
4.2 Global Colon & Rectal Carcinoma Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Colon & Rectal Carcinoma Market Size by Application (2015-2020)
5.2 Global Colon & Rectal Carcinoma Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colon & Rectal Carcinoma Market Size (2015-2020)
6.2 Colon & Rectal Carcinoma Key Players in North America (2019-2020)
6.3 North America Colon & Rectal Carcinoma Market Size by Type (2015-2020)
6.4 North America Colon & Rectal Carcinoma Market Size by Application (2015-2020)
7 Europe
7.1 Europe Colon & Rectal Carcinoma Market Size (2015-2020)
7.2 Colon & Rectal Carcinoma Key Players in Europe (2019-2020)
7.3 Europe Colon & Rectal Carcinoma Market Size by Type (2015-2020)
7.4 Europe Colon & Rectal Carcinoma Market Size by Application (2015-2020)
8 China
8.1 China Colon & Rectal Carcinoma Market Size (2015-2020)
8.2 Colon & Rectal Carcinoma Key Players in China (2019-2020)
8.3 China Colon & Rectal Carcinoma Market Size by Type (2015-2020)
8.4 China Colon & Rectal Carcinoma Market Size by Application (2015-2020)
9 Japan
9.1 Japan Colon & Rectal Carcinoma Market Size (2015-2020)
9.2 Colon & Rectal Carcinoma Key Players in Japan (2019-2020)
9.3 Japan Colon & Rectal Carcinoma Market Size by Type (2015-2020)
9.4 Japan Colon & Rectal Carcinoma Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Colon & Rectal Carcinoma Market Size (2015-2020)
10.2 Colon & Rectal Carcinoma Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Colon & Rectal Carcinoma Market Size by Type (2015-2020)
10.4 Southeast Asia Colon & Rectal Carcinoma Market Size by Application (2015-2020)
11 India
11.1 India Colon & Rectal Carcinoma Market Size (2015-2020)
11.2 Colon & Rectal Carcinoma Key Players in India (2019-2020)
11.3 India Colon & Rectal Carcinoma Market Size by Type (2015-2020)
11.4 India Colon & Rectal Carcinoma Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Colon & Rectal Carcinoma Market Size (2015-2020)
12.2 Colon & Rectal Carcinoma Key Players in Central & South America (2019-2020)
12.3 Central & South America Colon & Rectal Carcinoma Market Size by Type (2015-2020)
12.4 Central & South America Colon & Rectal Carcinoma Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Colon & Rectal Carcinoma Introduction
13.1.4 Pfizer Revenue in Colon & Rectal Carcinoma Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Bayer Healthcare
13.2.1 Bayer Healthcare Company Details
13.2.2 Bayer Healthcare Business Overview
13.2.3 Bayer Healthcare Colon & Rectal Carcinoma Introduction
13.2.4 Bayer Healthcare Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.2.5 Bayer Healthcare Recent Development
13.3 Spectrum
13.3.1 Spectrum Company Details
13.3.2 Spectrum Business Overview
13.3.3 Spectrum Colon & Rectal Carcinoma Introduction
13.3.4 Spectrum Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.3.5 Spectrum Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Colon & Rectal Carcinoma Introduction
13.4.4 Novartis Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Amgen
13.5.1 Amgen Company Details
13.5.2 Amgen Business Overview
13.5.3 Amgen Colon & Rectal Carcinoma Introduction
13.5.4 Amgen Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.5.5 Amgen Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Colon & Rectal Carcinoma Introduction
13.6.4 Roche Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Colon & Rectal Carcinoma Introduction
13.7.4 Merck Revenue in Colon & Rectal Carcinoma Business (2015-2020)
13.7.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Colon & Rectal Carcinoma Key Market Segments
Table 2. Key Players Covered: Ranking by Colon & Rectal Carcinoma Revenue
Table 3. Ranking of Global Top Colon & Rectal Carcinoma Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Colon & Rectal Carcinoma Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Colon Carcinoma Treatment
Table 6. Key Players of Rectal Carcinoma Treatment
Table 7. Global Colon & Rectal Carcinoma Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Colon & Rectal Carcinoma Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Colon & Rectal Carcinoma Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Colon & Rectal Carcinoma Market Share by Regions (2015-2020)
Table 11. Global Colon & Rectal Carcinoma Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Colon & Rectal Carcinoma Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Colon & Rectal Carcinoma Market Growth Strategy
Table 17. Main Points Interviewed from Key Colon & Rectal Carcinoma Players
Table 18. Global Colon & Rectal Carcinoma Revenue by Players (2015-2020) (Million US$)
Table 19. Global Colon & Rectal Carcinoma Market Share by Players (2015-2020)
Table 20. Global Top Colon & Rectal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon & Rectal Carcinoma as of 2019)
Table 21. Global Colon & Rectal Carcinoma by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Colon & Rectal Carcinoma Product Solution and Service
Table 24. Date of Enter into Colon & Rectal Carcinoma Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 27. Global Colon & Rectal Carcinoma Market Size Share by Type (2015-2020)
Table 28. Global Colon & Rectal Carcinoma Revenue Market Share by Type (2021-2026)
Table 29. Global Colon & Rectal Carcinoma Market Size Share by Application (2015-2020)
Table 30. Global Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 31. Global Colon & Rectal Carcinoma Market Size Share by Application (2021-2026)
Table 32. North America Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 34. North America Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 35. North America Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 36. North America Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 37. North America Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 38. Europe Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 40. Europe Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 42. Europe Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 44. China Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 45. China Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 46. China Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 47. China Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 48. China Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 49. China Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 50. Japan Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 52. Japan Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 54. Japan Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 58. Southeast Asia Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 60. Southeast Asia Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 62. India Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 63. India Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 64. India Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 65. India Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 66. India Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 67. India Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Colon & Rectal Carcinoma Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Colon & Rectal Carcinoma Market Share (2019-2020)
Table 70. Central & South America Colon & Rectal Carcinoma Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Colon & Rectal Carcinoma Market Share by Type (2015-2020)
Table 72. Central & South America Colon & Rectal Carcinoma Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Colon & Rectal Carcinoma Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Bayer Healthcare Company Details
Table 80. Bayer Healthcare Business Overview
Table 81. Bayer Healthcare Product
Table 82. Bayer Healthcare Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 83. Bayer Healthcare Recent Development
Table 84. Spectrum Company Details
Table 85. Spectrum Business Overview
Table 86. Spectrum Product
Table 87. Spectrum Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 88. Spectrum Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Product
Table 97. Amgen Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 98. Amgen Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Merck Company Details
Table 105. Merck Business Overview
Table 106. Merck Product
Table 107. Merck Revenue in Colon & Rectal Carcinoma Business (2015-2020) (Million US$)
Table 108. Merck Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colon & Rectal Carcinoma Market Share by Type: 2020 VS 2026
Figure 2. Colon Carcinoma Treatment Features
Figure 3. Rectal Carcinoma Treatment Features
Figure 4. Global Colon & Rectal Carcinoma Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Colon & Rectal Carcinoma Report Years Considered
Figure 8. Global Colon & Rectal Carcinoma Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Colon & Rectal Carcinoma Market Share by Regions: 2020 VS 2026
Figure 10. Global Colon & Rectal Carcinoma Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Colon & Rectal Carcinoma Market Share by Players in 2019
Figure 13. Global Top Colon & Rectal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon & Rectal Carcinoma as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Colon & Rectal Carcinoma Revenue in 2019
Figure 15. North America Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Colon & Rectal Carcinoma Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
副腎皮質がん治療の世界市場（～2026年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…- 尿路上皮がん治療の世界市場（～2026年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…
- 胸腺癌治療の世界市場（～2026年） Market Analysis and Insights: Global Thymic Carcinoma Treatment Market The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thymic Carcinoma Treatment Scope and Market Size Thymic Carci…
- 尿路上皮がん診断の世界市場（～2026年） Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis. The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold. Market Analysis and Insights: Global Urot…